The drug regulator has granted Serum Institute of India's Covishield and Bharat Biotech's Covaxin Covid-19 vaccines "conditional market authorisation".
'I4F- India-Israel Industrial R&D and Technological Innovation Fund' is a collaboration between the Department of Science and Technology (DST), the Government of India, and the Israel Innovation Authority.
EXAMIANS